Drugs / JW0108
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06955104 | Apr → Jul 2025 | hyperlipidemia | JW Pharmaceutical | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | JW0108 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06955104 ↗ |